Try our corporate solution for free!

Sputnik V doses bought from Russia 2022, by country

Number of doses of the COVID-19 vaccine Sputnik V ordered from Russia or agreed to be produced abroad as of January 2022, by country

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

January 2022



Survey time period

As of January 2022

Supplementary notes

* Algeria: number of doses to be supplied in January 2021.
Argentina: production was to start in June at one million doses per month, with prospects to increase it to 4-5 million doses per month in the future.
Belarus: planned monthly production at Belmedpreparaty.
Brazil: planned production per month in the first half of 2021.
China: 60 million by Shenzhen Yuanxing Gene-tech, 100 million per year by TopRidge Pharma, and 100 million by Hualan Biological Bacterin Inc.
Egypt: by Minapharm and its German subsidiary ProBioGen AG, per year.
India: production of over 100 million doses per year by Hetero, up to 200 million per year by Virchow Biotech, 200 million by Stelis Biopharma, 252 million by Gland Pharma, 100 million per year by Panacea Biotec, and 300 million per year by Serum Institute of India (SII). The production is also planned by Morepen Laboratories.
Italy: production in 2021.
Kazakhstan: production by Karaganda Pharmaceutical Complex (KPC).
Mongolia: number of doses ordered as of March 2021; discussions on more deliveries were ongoing.
Serbia: planned production volume as of March 14, 2021.
South Korea: more than 150 million per year by GL Rapha, 500 million doses per year by a consortium including GL Rapha и ISU ABXIS, and 100 million per month by a consortium led by Huons Global Co Ltd.
Uzbekistan: production by Jurabek Laboratories.
Vietnam: expected annual production of 100 million doses by Vabiotech and 40 million by T&T Group.

** Plans to produce Sputnik V on its territory.
The statistic has been compiled from various local and international news sources, the Russian Direct Investment Fund, and national health ministries.

Figures have been rounded. Vaccine doses offered in humanitarian aid packages are not included.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus (COVID-19) in Russia "

Statistics on Coronavirus (COVID-19) in Russia



Prevention & diagnostics


Medicines and health products


Economic impact


Impact on selected industries


Public opinion


Further related statistics

Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.